Recent Articles from GlobeNewswire

Golar LNG Limited (NASDAQ: GLNG) (“Golar” or “the Company”) announces today that it has agreed to acquire the LNG carrier Grace Dahlia from NYK Line. The Grace Dahlia was built in 2013 and has been maintained and managed to the highest operational standards by NYK Line.

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s Sporting Goods” or the “Company”) (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick’s Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the “Class Period”).

HERNDON, Va., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) will host an audio webcast to review its third quarter 2026 results on Wednesday, November 4, 2026, at 5:00 p.m. Eastern Time.

Nearly all newly originated fix-and-flip, bridge and new construction loans will receive direct servicing from Easy Street Capital’s team

CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development

Company doubles its year-over-year ARR growth rate as new capabilities extend into engineering, customer support and AI workflows.

News Provided by Market Updates on behalf of Western Star Resources Inc.

In running order management, credit, collections, cash application, payments, disputes and deductions end to end, Stuut's customers are cutting DSO by 47%, with over $3 billion already moving through the platform.

Fire departments and EMS organizations transporting to UH now receive same-shift patient outcomes and continuing education credit

LONG BEACH, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its third quarter 2026 financial results on Monday, November 2nd after market hours. The Company will hold a conference call to discuss these financial results on Tuesday, November 3rd at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time).

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).

EVOLVE Government Summit will convene public sector and technology leaders to explore how agencies can securely bring AI to data anywhere while maintaining governance and control.

FAIRFAX, Va., Oct. 07, 2026 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE American: WYY), a leading provider of Secure Mobile Management Solutions, will be attending the LD Micro 20th Annual Main Event from October 19-21, 2026 at the Luxe Sunset Blvd Hotel in Los Angeles, CA.

Veteran finance executive brings enterprise financial leadership, fundraising experience, and a track record supporting two successful exits

First-of-its-kind event brought home service professionals together across 98 cities and 46 states to connect, share insights and strengthen the trades community

CTC Develops Machine Learning Tool to Protect Against Adversarial Attacks and Privacy Vulnerabilities in Defense Applications

Small businesses can try 800.com's AI receptionist free for seven days on missed and after-hours calls

The new practice brings V2’s integrated communications expertise to technology companies navigating the complex public sector marketplace across federal, state, local, higher education and healthcare audiences

Naples, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Naples Comprehensive Health (NCH) announced today that Danny Hogan has been named its next Chief Financial Officer. Hogan joined the organization on Oct. 5.

New analysis finds data center water withdrawals vary widely, from a daily average of 270 gallons to 3.9 million gallons. Withdrawals peak during hot and dry periods, when competing demands are typically high and water supplies are most constrained.

Financial services professionals, investors, and business leaders can now access EIU’s independent economic forecasts and country and industry intelligence directly within AlphaSense’s platform

A transformative AI-powered technology intelligence platform trained on billions of proprietary data points annually, real use cases, and hundreds of thousands of tracked tech companies.

Trust for Public Land highlights Indigenous-led conservation nationwide, including a first major milestone in the effort to return nearly 30,000 acres to the Penobscot Nation and protection of nearly 200,000 acres with more than 70 Tribal nations

CHICAGO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Healthcare organizations focus on changes in patient demand and case complexity as targeted service line strategies continue to be a lever for growth. Drug and supply expenses continue to outpace labor costs, while regional variations and hospital size reveal materially different cost structures, according to Strata Decision Technology's H1 2026 Strata Performance Trends report.

The acquisition follows the recent unification of Xpress Wellness and Integrity Urgent Care under a single masterbrand – Integrity Care Group

SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Brad Jerome of Legacy Financial Group has joined LPL Financial's broker-dealer and Registered Investment Advisor (RIA) platforms. He reported serving approximately $175 million in advisory, brokerage and retirement plan assets* and joins LPL from Osaic.

DALLAS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- For a fifth year, Highland Homes has been named a gold award winner in the best homebuilder category in the Dallas Morning News Best in DFW People’s Choice Awards.

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) on behalf of investors that purchased or otherwise acquired GoDaddy common stock between September 3, 2025 and February 24, 2026 (the “Class Period”).

Renewal extends a long-standing relationship with a key Dutch government agency through April 2030 and expands Circle8’s multi-year public-sector contract base.

Advanced Grid Reliability Offerings Help Utilities Reduce Outage Duration and Prevent Grid Failures Before Customers Are Impacted 

LAS VEGAS, NEVADA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and its joint venture partner Austrianova, today announced the first joint steering committee meeting for their collaboration with Ospedale San Raffaele S.r.l. (OSR), to discuss the initial research program for evaluating an encapsulated beta-cell replacement approach for insulin-dependent diabetes.

  

Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder

Highlights Include Landmark Agreement with Nebius, Expansion of Power Portfolio, and Funding Strategy for CLT1

New dedicated website will showcase the evolution of Fusemachines’ AI Twin technology while inviting discussion on the technical, legal, social, and human implications of AI that can represent people at work

The guest appreciation celebration follows Dave’s recently being named Yelp’s No. 1 Most Loved Brand*

NOVATO, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million. Ultragenyx received the PRV upon U.S. Food and Drug Administration (FDA) approval of GENGLYCOS™ (pariglasgene brecaparvovec-opnr), also known as DTX401, the first treatment designed to address the underlying cause of glycogen storage disease type Ia (GSDIa).

PLANTATION, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, today announced its participation in two upcoming investor conferences in New York City during October 2026.

Preclinical package also shows more than 2.5-fold survival extension in advanced PDAC models; Company contrasts a non-RAS, differentiation-based mechanism with the clinical benchmark set by RASONQUE (daraxonrasib)

BOCA RATON, FL, Oct. 07, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company" or "DeFi Dev Corp."), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced that Chief Executive Officer Joseph Onorati and Chief Strategy Officer Dan Kang will present at the 2026 Maxim Growth Summit, taking place October 12–14, 2026, at the Hard Rock Hotel in New York City.

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

Paris and New York, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Cyllene Therapeutics SAS (“Cyllene Tx”), a leader in site-specific, non-systemic DNA medicines for the treatment of prevalent chronic neurological disorders, today announced presentation of interim clinical data from the first two dose cohorts of its Phase 1b/2a trial showing that treatment with EG110A resulted in consistent and clinically relevant reductions in urinary incontinence episodes up to 52 weeks in people with spinal cord injury (“SCI”) with neurogenic detrusor overactivity (“NDO”). This debilitating and prevalent bladder disorder is characterized by uncontrolled urinary incontinence. The data, presented at the 56th International Continence Society Annual Meeting in Maastricht, the Netherlands, also showed EG110A to be well tolerated, with no severe drug related side effects or dose-limiting toxicity.

Integrated Technology Supports Faster Transactions and Streamlined Operations Across Sports, Concerts and Global Events

Management to Review Third-Quarter Performance and Provide Updates on Ongoing Initiatives

Agreement with Mediplexus, a subsidiary of Korean CRO C&R Research, establishes a new Asia Pacific distribution channel for OneMedNet’s first-party, direct-from-source multimodal Real World Data

 

Nature Communications publication provides new evidence that Vaccinex’s pepinemab may help reshape the tumor environment to support a coordinated immune attack on cancer, potentially complementing checkpoint inhibitors and other immunotherapies

Fall 2026 release brings pipeline-ready Markdown extraction, higher-level document generation, more consistent editing APIs, and more resilient document capture directly into Apryse SDKs

Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions 

TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, that CliniQuantum Ltd. (“CliniQuantum”), NeuroThera’s  majority owned subsidiary, reported that its Graphics Processing Unit- accelerated (“GPU”) quantum-simulation platform achieved an approximately 16.8-fold computational acceleration using a single machine with 64 cores (x86_64) and a single NVIDIA T4 Tensor Core GPU compared with the same 64-vCPU machine with only Central Processing Unit (“CPU”) implementation.

Built as an alternative to traditional private equity, where local owners keep their focus on their teams and customers while American Service Partners provides institutional-grade back-end systems and leading AI synergies

Matthew Latino appointed CFO; Michael Bishop to continue as senior advisor

Boat, watersports, RV, golf cart and powersports businesses can now get answers from their BookingCentral data in seconds

As the FDA opens the door to non-animal safety testing, VivoSim's human-relevant models are already helping lower drug costs

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company’s investor relations website offering an overview of the financial results.

AVENTURA, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced preliminary, unaudited revenue expectations for the third quarter ended September 30, 2026.

Si829x platform with ProVCD™ technology moves from development to pre-production release for EV traction inverters

Base award supports late-stage development, regulatory approval activities, and initial procurement of Kaléo’s next-generation 2-PAM auto-injector for organophosphate and nerve agent poisoning

PLANO, Texas, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced that CEO Rod Baltzer and CFO Joe Nelson will present at three upcoming investor conferences, offering investors opportunities to learn more about the Company’s technology, commercialization strategy and progress toward deploying deep borehole disposal for nuclear waste.

Card-linked mobile app turns gas purchases into micro-offsets for $0.23 per gallon

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (“UWM Holdings” or the “Company”) (NYSE: UWMC) on behalf of investors that purchased or otherwise acquired UWM Holdings securities between March 9, 2026 and August 5, 2026 (the “Class Period”).

CARSON CITY, Nev., Oct. 07, 2026 (GLOBE NEWSWIRE) -- American Lithium Minerals Inc. (OTC: AMLM) today announced that Worldwide Diversified Holdings, Inc. (“Worldwide”) has agreed to convert its outstanding note into AMLM common shares. Under the agreed structure, Worldwide will facilitate an initial transfer of one AMLM common share for every ten Worldwide common shares, scheduled to be completed in the fourth quarter, advancing AMLM’s capital-markets strategy.

ANN ARBOR, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Esperion, a company wholly-owned by ARCHIMED, today announced that it has entered into a settlement agreement with Renata Limited (along with an affiliate). This agreement resolves the patent litigation brought by Esperion against Renata in response to Renata’s Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of NEXLETOL and NEXLIZET prior to the expiration of the applicable patents. Pursuant to the agreement, Renata has agreed not to market a generic version of either NEXLETOL or NEXLIZET in the United States prior to April 19, 2040, unless certain limited circumstances customarily included in these types of agreements occur.

DALLAS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the third quarter of 2026 after market on Wednesday, October 21, 2026. Executive management will host a conference call and webcast to discuss third quarter 2026 operating results on Wednesday, October 21, 2026, at 5:00 p.m. EDT.

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Madison Realty Capital, working with Newbond Holdings, has provided a loan to a joint venture between Schulte Hospitality Group and an institutional investment partner for Hotel Washington, a 326-key luxury independent hotel located at 515 15th Street NW in Washington, D.C. Schulte Hospitality Group, a boutique and lifestyle hotel specialist managing over 250 properties across 40 states and five countries, operates the property directly.

Earnings Release and Conference Call Scheduled for November 4, 2026

ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval

- Three-phase, 36-month award aims to extend BrainEx perfusion from 24 hours to up to two weeks, enabling longitudinal studies of human brain biology and therapeutic responses -

Caregivers say they need clearer pain management plans, earlier education, and practical support on non-opioid options before a loved one undergoes surgery

Vancouver, BC, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour”, “SYH” or the “Company”) is pleased to announce the commencement of drilling at the Getty East Uranium Joint Venture (“Getty East” or the “Property”) representing the first phase of drilling in 2026 at this newly established property. The 3,105-hectare Getty East Property, comprising one claim, is a part of the broader Russell Lake project area and joint venture with Denison Mines Corp. (“Denison”) (TSX: DML) (NYSE American: DNN). The Russell Lake Joint Ventures are strategically located in the central portion of the eastern Athabasca Basin of northern Saskatchewan adjacent and proximal to Denison’s flagship Wheeler River project. There is also access to significant regional infrastructure, including an exploration camp, provincial highways, and the provincial power grid.

Health care technology leaders say operational readiness across people, processes, workflows and revenue cycle is as important as technical preparation

Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and a well-tolerated safety profile with no high-grade CRS or ICANS and no cases of IEC-HS 

Combination of ruvonoflast and semaglutide produced greater reductions in hsCRP versus semaglutide monotherapy

New AI-powered service combines Aptean’s domain experts, industry-specific software, decades of vertical data, and AI ecosystem

BOSTON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases, today announced positive topline results from ARISE, its randomized, double-blind, placebo-controlled Phase 3 trial of once-daily oral solengepras as an adjunctive treatment for people with Parkinson’s disease experiencing motor fluctuations on levodopa and other Parkinson’s medications. Solengepras is a potential first-in-class therapy that targets the striatal indirect pathway through a novel receptor (GPR6) and has no direct impact on dopamine receptors. The ARISE results support its potential to address both motor and non-motor symptoms of Parkinson’s disease.